Global male infertility market is expected to exhibit a steady growth during the forecast period owing to growing awareness of people about such disorders and becoming more concerned about own health overcoming the social stigma and guilt.
According to the WHO, 1 in every 4 couples in developing countries is expected to be affected by infertility. The couples who are not able to have a child are going for the expensive treatment options for fulfilling their desires which leads to growth of male infertility market.
Growing prevalence of male infertility due to increasing age, drugs and alcohol consumption, changes in the lifestyle, environmental factors, genetic abnormalities and medications affecting spermatogenesis are also expected to boost in the male infertility market.
Full research report on male infertility market Analysis:
Growing cutting age technologies in the diagnosis and treatment of male infertility is also expected to boost the market growth. Most of these treatments and diagnosis are costly. However, rising spending expenditure majorly in the developed nations is fueling the growth of male infertility market. Proteomics and microarray technology are the advancements in the customized diagnostic treatments for male infertility.
Male infertility market includes various diagnostics and screening tests. However, the major hurdles existing in the accurate diagnosis of male infertility lead to complication in understanding of the etiology and epidemiology of the disorder.
Various semen analysis techniques are ultrasonography, endocrine evaluation, post-ejaculatory urinalysis, specialized clinical tests on semen and sperm, sperm viability tests, sperm agglutination, quantification of leukocytes in semen, sperm DNA fragmentation test, sperm penetration assay tests for anti-sperm antibodies, oxidative stress analysis, and genetic screening.
Get more information on male infertility market or request for TOC of this research report at:
North America is expected to be the largest share holding market during the forecast period due to the factors such as availability of well established healthcare infrastructure and high level of awareness amongst the people about the disorders. Moreover the numbers of people suffering from such disorders are also high in this region.
DNA fragmentation is an advanced technique for semen analysis in the well developed nations like the U.S. and UK. Increasing medical tourism in the U.S. is also boosting the male infertility market. However, it is yet not yet fully utilized for routine analysis in the researched laboratories of the emerging nations such as South Africa, India and China. The major reason is the high cost of such diagnostic tests and treatment for male infertility.
Asia Pacific is expected to grow fast during the forecast period primarily due to the factors such as increasing awareness of people about the male disorders such as male infertility and they are more rapidly overcoming the social taboo and feeling of guilt about this disorder. Moreover, increasing healthcare expenditure is also the factor boosting the growth of the male infertility market.
Market players in male infertility market are ASKA Pharmaceutical Co. Ltd, Cordex Pharma, Inc., EMD Serona Inc., Pantarhei Bioscience B, Access Pharmaceuticals, Inc., Merck Serono, Halotech DNA SL, ZydusCadila Healthcare Limited, SCSA diagnostics, Andrology Solutions and, Intas Pharmaceuticals Ltd.
View more reports of this category by Grand View Research at:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States